Optimization of the treatment with beta-lactam antibiotics in critically ill patients—guidelines from the French Society of Pharmacology and Therapeutics (Société Française de Pharmacologie et Thérapeutique—SFPT) and the French Society of Anaesthesia and Intensive Care Medicine (Société Française d’Anesthésie et Réanimation—SFAR)

BACKGROUND: Beta-lactam antibiotics (βLA) are the most commonly used antibiotics in the intensive care unit (ICU). ICU patients present many pathophysiological features that cause pharmacokinetic (PK) and pharmacodynamic (PD) specificities, leading to the risk of underdosage. The French Society of P...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Crit Care
Autori principali: Guilhaumou, Romain, Benaboud, Sihem, Bennis, Youssef, Dahyot-Fizelier, Claire, Dailly, Eric, Gandia, Peggy, Goutelle, Sylvain, Lefeuvre, Sandrine, Mongardon, Nicolas, Roger, Claire, Scala-Bertola, Julien, Lemaitre, Florian, Garnier, Marc
Natura: Artigo
Lingua:Inglês
Pubblicazione: BioMed Central 2019
Soggetti:
Review
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6441232/
https://ncbi.nlm.nih.gov/pubmed/30925922
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13054-019-2378-9
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi